Results 81 to 90 of about 2,623 (125)

Leveraging Machine Learning to Predict Warfarin Sensitivity in the Puerto Rican Population: A Pharmacogenomic Approach. [PDF]

Int J Environ Res Public Health
Martínez-Jiménez JE, Ortega-Lampón Y, Cedres-Rivera D, Heredia-Negrón F, Roche-Lima A, Duconge J.   +5 more
europepmc   +1 more source

Pharmacogenomic landscape of a Moroccan cohort: enhancing global diversity and addressing the North African gap. [PDF]

Sci Rep
Kartti S, Chemao-Elfihri MW, Hakmi M, Aherkou M, ElJaoudi R, Balouch L, Fahime EE, Belyamani L, Boutayeb S.   +8 more
europepmc   +1 more source

Population-Scale Pharmacogenomic Profiling in the Western Balkan Populations. [PDF]

Pharmaceuticals (Basel)
Ćurić I, Pavlović Đ, Jelovac M, Stanković B, Kotur N, Gašić V, Ristivojević B, Tošić N, Predojević-Samardžić J, Vukovic M, Roganovic J, Anastasovska V, Miljanovic O, Patrinos GP, Karamperis K, Mitropoulou C, Dolzan V, Lucafò M, Stocco G, Pavlović S, Zukić B.   +20 more
europepmc   +1 more source

Managing Secondary Findings from Germline Pharmacogenomic Testing. [PDF]

J Pers Med
Lee YM, Kearney E, Kisor DF, Farrell CL.
europepmc   +1 more source

Protein Levels of 16 Cytochrome P450s and 2 Carboxyl Esterases Using Absolute Quantitative Proteomics: CYP2C9 and CYP3A4 Are the Most Abundant Isoforms in Human Liver and Intestine, Respectively. [PDF]

Pharmaceuticals (Basel)
Grangeon A, Arwood ML, Thacker D, Gaudette F, Turgeon J, Michaud V.   +5 more
europepmc   +1 more source

Pharmacogenomic diversity among Arab populations: A systematic review. [PDF]

iScience
Al-Mahayri ZN, Alqasrawi MN, Khasawneh LQ, Altoum SM, Albawa'neh AS, Dabaghie L, Ali BR.   +6 more
europepmc   +1 more source

Design and validation of a clinical whole genome sequencing-based assay for patient screening in a large healthcare system. [PDF]

Front Mol Biosci
Wagner JT, Welle JT, Lucas Beckett IA, Emery KR, Cosgrove BA, Olszewski K, Wagner N, Bower TC, Yuan LC, Shull EM, Jade K, Clemens J, Magis AT, Campbell MB, Gordon OK, Bifulco CB, Piening BD.   +16 more
europepmc   +1 more source

Prevalence of actionable pharmacogenomic variants in Brazilian patients with cancer. [PDF]

Front Pharmacol
Schuch JB, Botton MR, De Baumont AC, Curzel G, Cadore NA, Bordignon C, Rosa ML, Vasconcellos VF, Barros LAR, Souza CP, Barra WF, Louzeiro DLC, Notari A, de Menezes JJ, Liedke PER, Bertollo GA, Gongora ABL, Ascenco HG, Kowalski-Neto E, Oppermann CP, Werutsky G, Santos EM, Brandão FS, Freitas-Junior R, Nogueira-Rodrigues A, Mancini ALC, Bessel M, Macedo GS, Rosa DD.   +28 more
europepmc   +1 more source

Genotype-predicted drug response phenotypes and their co-occurrence with dispensed medicines among 738,531 participants in the UK Our Future Health study

Rentsch CT, Bhaskaran K, Pavicic M, Warren HR, Matthewman J, Barry E, Rafi I, Hayward J, Gerada C, Shah A, Munroe PB, Silver MJ, Pirmohamed M.   +12 more
europepmc   +1 more source

Clinical Application of Pharmacogenomics in Stroke Management: Current Evidence and Future Directions. [PDF]

J Stroke
Lee KJ, Kang M, Lee EJ, Oh J, Han NY, Lee JY, Lee JY, Lee SJ, Debette S, Paré G, Woo D, Eldeiry A, Kim YS, Kim J, Park JM, Lee J, Sung J, Choi JC, Bae HJ.   +18 more
europepmc   +1 more source